Paper37097366
Randomized Trials vs Real-world Evidence: How Can Both Inform Decision-making?
Sheldrick RC. JAMA, 2023. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Randomized Trials vs Real-world Evidence: How Can Both Inform Decision-making? Papers, record 37097366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37097366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Decision Making | Major topic |
| Randomized Controlled Trials as Topic | Major topic |
| Life Change Events | |
| Research Design |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 37097356 | Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials. | https://conductscience.org/library/papers/37097356 |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42633174 | Real-World Clinical Efficacy of Food and Drug Administration-Approved Budesonide Oral Suspension Across Histologic, Endoscopic, and Symptomatic Outcomes. | Gastro Hep Adv | 2026 | https://conductscience.org/library/papers/42633174 | PubMed |
| 42548438 | Using Real-World Research to Study the Impact of Chronic Daily Therapy Discontinuation in Cystic Fibrosis: The Home-Reported Outcomes in Cystic Fibrosis 2 Study Design. | CHEST Pulm | 2024 | https://conductscience.org/library/papers/42548438 | PubMed |
| 42499182 | Defining the Efficacy of Meningococcal B Vaccines Against Gonococcal Acquisition: The Current Landscape. | J Int AIDS Soc | 2026 | https://conductscience.org/library/papers/42499182 | PubMed |
| 42443777 | A stakeholder-inclusive conceptual framework for modeling routinely collected health data for therapeutic decision-making illustrated by means of multistate models. | BMC Med Res Methodol | 2026 | https://conductscience.org/library/papers/42443777 | PubMed |
| 42389740 | Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients. | Int J Cardiol Heart Vasc | 2026 | https://conductscience.org/library/papers/42389740 | PubMed |
| 42387883 | Preoperative physiotherapy and one-year patient-reported outcomes after primary total knee arthroplasty: a registry-based cohort study of 1,688 patients. | J Rehabil Med | 2026 | https://conductscience.org/library/papers/42387883 | PubMed |
| 42132959 | Spironolactone and clinical outcomes in patients with alcohol use disorder and comorbid hypertension: a target trial emulation study. | Psychopharmacology (Berl) | 2026 | https://conductscience.org/library/papers/42132959 | PubMed |
| 42127972 | Real-world effectiveness of thrombectomy for basilar artery occlusion: lessons beyond the ATTENTION and BAOCHE trials. | Eur Stroke J | 2026 | https://conductscience.org/library/papers/42127972 | PubMed |
| 42012779 | Interleukin-23 Inhibitors in Inflammatory Bowel Disease. | BioDrugs | 2026 | https://conductscience.org/library/papers/42012779 | PubMed |
| 41953701 | Real-world glycemic control, exploratory cardiorenal indicators, and safety of polyethylene glycol loxenatide versus semaglutide in type 2 diabetes patients: a Chinese two-center retrospective cohort study. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41953701 | PubMed |
| 41810148 | Target trial emulation in oncology: current use and future directions. | Mil Med Res | 2025 | https://conductscience.org/library/papers/41810148 | PubMed |
| 41646264 | Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment. | ESMO Gastrointest Oncol | 2025 | https://conductscience.org/library/papers/41646264 | PubMed |
| 41620660 | Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study. | J Headache Pain | 2026 | https://conductscience.org/library/papers/41620660 | PubMed |
| 40956583 | Integrated Behavioral Health Services and Psychosocial Symptoms in Children. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40956583 | PubMed |
| 40899334 | What we cannot miss in clinical trials on compression therapy. | Phlebology | 2026 | https://conductscience.org/library/papers/40899334 | PubMed |
| 40817421 | Age and Sex Differences in Adverse Events Associated With Antipsychotics: An Analysis of the FDA Adverse Events Database. | Int J Geriatr Psychiatry | 2025 | https://conductscience.org/library/papers/40817421 | PubMed |
| 40725552 | Why High-Volume Post-Dilution Hemodiafiltration Should Be the New Standard in Dialysis Care: A Comprehensive Review of Clinical Outcomes and Mechanisms. | J Clin Med | 2025 | https://conductscience.org/library/papers/40725552 | PubMed |
| 40600300 | Real-World Use of Phentermine and Topiramate for Adolescent Obesity: Retrospective Effectiveness and Safety Analysis. | Child Obes | 2025 | https://conductscience.org/library/papers/40600300 | PubMed |
| 40548174 | Clinical Utility of Long-Acting Injectable Risperidone in Schizophrenia and Bipolar I Disorder: A Review of Clinical Studies. | Psychol Res Behav Manag | 2025 | https://conductscience.org/library/papers/40548174 | PubMed |
| 40529115 | Faricimab Outcomes in Chorioretinal Disorders: Indian Real-World Analysis (FOCUS Study). | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/40529115 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37097366
GET https://conductscience.org/api/papers/v1/37097366/cited_by?page=2